Opens in a new tab or window The chronic myeloid leukemia drug nilotinib (Tasigna) improved biomarkers and cognitive outcomes ...

The Penguin recently aired its sixth episode. The episode was filled with interesting twists and turns, leaving viewers on ...

Oswald Cobblepot's mother suffers from Lewy Body Dementia and here's all you need to know about the incurable disease.

No history of medication could be elicited. Dementia with Lewy bodies (DLB) is a clinically defined syndrome and is claimed to be the second most common type of degenerative dementia among older ...

Lewy body dementia (LBD) is a progressive neurodegenerative disease that shares traits with both Parkinson's disease and Alzheimer's disease but can be more difficult to diagnose. Symptoms can ...

Attempts to discover a breakthrough dementia drug might be drawing attention these days, but traditional medicinal products ...

Nilotinib (Tasigna) — a drug for myeloid leukemia — improved biomarkers and cognitive outcomes in study participants with dementia with Lewy bodies, a new study finds.

About 7 million Americans live with chronic neurodegenerative diseases such as Parkinson’s disease, amyotrophic lateral ...

CervoMed (CRVO) will deliver an oral presentation providing detailed safety and efficacy results from its completed RewinD-LB Phase 2b clinical ...

Nilotinib, a drug approved by the US Food and Drug Administration (FDA) to treat chronic myeloid leukemia, improved ...